HPV-16 Vaccination
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HPV-16 Vaccination, covering 2023-04-18 to 2025-09-11. Get the full timeline:
Most recent: Clinical Trial Update: HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma [Phase 2]